437 related articles for article (PubMed ID: 9127318)
21. Selective inhibition of P-glycoprotein expression in multidrug-resistant tumor cells by a designed transcriptional regulator.
Xu D; Ye D; Fisher M; Juliano RL
J Pharmacol Exp Ther; 2002 Sep; 302(3):963-71. PubMed ID: 12183653
[TBL] [Abstract][Full Text] [Related]
22. Amplification and expression of EGFR and ERBB2 in Wilms tumor.
Vasei M; Modjtahedi H; Ale-Booyeh O; Mosallaei A; Kajbafzadeh AM; Shahriari M; Ghaderi AA; Soleymanpour H; Kosari F; Moch H; Sauter G
Cancer Genet Cytogenet; 2009 Oct; 194(2):88-95. PubMed ID: 19781441
[TBL] [Abstract][Full Text] [Related]
23. Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis.
Galimberti S; Guerrini F; Carulli G; Fazzi R; Palumbo GA; Morabito F; Petrini M
Eur J Haematol; 2004 Jan; 72(1):45-51. PubMed ID: 14962262
[TBL] [Abstract][Full Text] [Related]
24. Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line.
Hazen-Martin DJ; Re GG; Garvin AJ; Sens DA
Am J Pathol; 1994 May; 144(5):1023-34. PubMed ID: 8178926
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical analysis of gamma catenin in Wilms' tumors.
Basta-Jovanovic G; Gvozdenovic E; Dimitrijevic I; Brasanac D; Jovanovic M; Kalezic N; Baralic I; Radojevic-Skodric S; Arsic D
Fetal Pediatr Pathol; 2008; 27(2):63-70. PubMed ID: 18568994
[TBL] [Abstract][Full Text] [Related]
26. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
[TBL] [Abstract][Full Text] [Related]
27. Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells.
Brouillard F; Tondelier D; Edelman A; Baudouin-Legros M
Cancer Res; 2001 Feb; 61(4):1693-8. PubMed ID: 11245485
[TBL] [Abstract][Full Text] [Related]
28. Expression of apoptosis, cell proliferation, and drug resistance genes in pediatric Wilms' tumors.
Ramachandran C; Melnick SJ; Escalon E; Jhabvala P; Khatib Z; Alamo A; Smith S
Anticancer Res; 2000; 20(5C):3759-65. PubMed ID: 11268451
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.
Comerford KM; Wallace TJ; Karhausen J; Louis NA; Montalto MC; Colgan SP
Cancer Res; 2002 Jun; 62(12):3387-94. PubMed ID: 12067980
[TBL] [Abstract][Full Text] [Related]
30. Expression and localization of HGF and met in Wilms' tumours.
Alami J; Williams BR; Yeger H
J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645
[TBL] [Abstract][Full Text] [Related]
31. Effect of hyperthermia 42.5 degrees C/120 min on 3H-thymidine incorporation in different tissue components of Wilms' tumors: an in vitro study.
Willnow U; Dumon K; Godehardt E
Klin Padiatr; 1996; 208(4):145-50. PubMed ID: 8776702
[TBL] [Abstract][Full Text] [Related]
32. A gene expression signature for relapse of primary wilms tumors.
Li W; Kessler P; Yeger H; Alami J; Reeve AE; Heathcott R; Skeen J; Williams BR
Cancer Res; 2005 Apr; 65(7):2592-601. PubMed ID: 15805255
[TBL] [Abstract][Full Text] [Related]
33. Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells.
Fraizer GE; Bowen-Pope DF; Vogel AM
J Cell Physiol; 1987 Oct; 133(1):169-74. PubMed ID: 2444606
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
Yun K; Fidler AE; Eccles MR; Reeve AE
Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
[TBL] [Abstract][Full Text] [Related]
36. Expression of the multiple drug resistance gene in human renal cell carcinoma depends on tumor histology, grade, and stage.
Tobe SW; Noble-Topham SE; Andrulis IL; Hartwick RW; Skorecki KL; Warner E
Clin Cancer Res; 1995 Dec; 1(12):1611-5. PubMed ID: 9815963
[TBL] [Abstract][Full Text] [Related]
37. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
Vu TH; Chuyen NV; Li T; Hoffman AR
Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
[TBL] [Abstract][Full Text] [Related]
38. Restoration of p53 function in anaplastic Wilms' tumor.
Delatte SJ; Hazen-Martin DJ; Re GG; Kelly JR; Sutphin A; Tagge EP
J Pediatr Surg; 2001 Jan; 36(1):43-50. PubMed ID: 11150436
[TBL] [Abstract][Full Text] [Related]
39. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
[TBL] [Abstract][Full Text] [Related]
40. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]